Health Trials

Myeloablative Allogeneic Hematopoietic Cell Transplantation

1

Review clinical trials related to Myeloablative Allogeneic Hematopoietic Cell Transplantation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Intraoral Photobiomodulation Therapy to Prevent Oral Mucositis in Patients Undergoing Hematopoietic Cell Transplantation

This is a single center pilot study evaluating intraoral photobiomodulation for the prevention of oral mucositis in patients undergoing myeloablative allogeneic hematopoietic cell transplantation (alloHCT). Patients who are planned for alloHCT will receive daily intraoral photobiomodulation therapy (PBMT) using a novel LED device. The name of the study device involved in this study is: \- THOR LX2.3 with LED Lollipop

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Dana-Farber Cancer InstituteUpdated: Dec 15, 2025Locations: 1
Eligibility criteria

Planned to undergo myeloablative allogeneic HCT using FluBu4 conditioning and Ta... [+2]

Participants who have had treatment with intraoral PBMT within four weeks of adm... [+3]

Read more